Inotiv Inc reports results for the quarter ended in January - Earnings Summary

Inotiv

09/08/2024 06:43

* Inotiv Inc  NOTV.OQ  reported a quarterly adjusted loss
of 100
cents​​ per share for the quarter ended in January, lower than
the same quarter last year, when the company reported EPS of 7
cents.  The mean expectation of three analysts for the quarter
was for a loss of 83 cents per share. Wall Street expected
results to range from -85 cents to -82 cents per share.
    * Revenue fell 32.8% to $105.79 million from a year ago;
analysts
expected $123.40 million. 
    * Inotiv Inc's reported EPS for the quarter was a loss of
$1.00​.
    * The company reported a quarterly loss of $26.09 million.
    * Inotiv Inc shares had risen by 1.2% this quarter and
lost 54.2%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 882.4% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Inotiv Inc is
$2.00 
This summary was machine generated from LSEG data August 9 at
05:43 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.83          -1.00          Missed
 Mar. 31 2024      -0.54          -1.86          Missed
 Dec. 31 2023      -0.85          -0.60          Beat
 Sep. 30 2023      -0.33          -0.38          Missed